Lithium and anticonvulsants such as valproic acid have the same end result: a more stable life for people with bipolar disorder. Now it seems they may also affect the same biochemical pathway in the brain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Williams, R.S.B, Cheng, L., Mudge, A.W., Harwood, A.J. A common mechanism of action for three mood-stabilizing drugs. Nature, 417 292–295 (2002).
Berridge, M.J., Downes, C.P. & Hanley, M.R. Neural and developmental actions of lithium: A unifying hypothesis. Cell. 59, 411–419 (1989).
Manji, H.K. & Chen, G. PKC, MAP kinases and the bcl-2 family of proteins as long term targets for mood stabilizers. Mol. Psychiatry 7, S46–56 (2002).
Lenox, R.H. & Hahn, C.G. Overview of the mechanism of action of lithium in the brain: Fifty-year update. J. Clin. Psychiatry. 61 (Suppl. 9), 5–15 (2000).
Niculescu, A.B. 3rd & Kelsoe, J.R. Convergent functional genomics: Application to bipolar disorder. Ann Med. 33, 263–271 (2001).
Klein, P.S. & Melton, D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8455–8459 (1996).
Maes, M. et al. Alterations in plasma prolyl endopeptidase activity in depression, mania and schizophrenia; effects of antidepressants, mood stabilizers and antipsychotic drugs. Psychiatry Res. 58, 217–225 (1995).
Duman, R.S. Synaptic plasticity and mood disorders. Mol. Psychiatry 7, 29–34 (2002).
Drevets, W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 11, 240–249 (2001).
Chen, G., Einat, H., Yuan, P. & Manji, H.K. Evidence for the involvement of the MAP/ERK signaling cascade in mood modulation. Biol. Psychiatry (in the press).
Tsai, G. & Coyle, J.T. N-acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 46, 531–540 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coyle, J., Manji, H. Getting balance: Drugs for bipolar disorder share target. Nat Med 8, 557–558 (2002). https://doi.org/10.1038/nm0602-557
Issue Date:
DOI: https://doi.org/10.1038/nm0602-557
This article is cited by
-
Lithium-Induced Gray Matter Volume Increase As a Neural Correlate of Treatment Response in Bipolar Disorder: A Longitudinal Brain Imaging Study
Neuropsychopharmacology (2010)
-
Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?
Molecular Psychiatry (2008)
-
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder
Molecular Psychiatry (2008)
-
Pharmacogenetics and bipolar disorder
The Pharmacogenomics Journal (2004)
-
Response to lithium treatment in bipolar disorder as a pharmacogenetic phenotype
Current Psychosis & Therapeutics Reports (2004)